10-Q/A

Quarterly Report

BIOSYNERGY INC

0001437749-22-007349

← back to feed

Filed: 4 years ago Mar 28, 2022 12:00 AM ET
Period of report: —

Amendment. Amends a previously filed report.

On SEC.gov

Filing index ↗

Financials in this filing

Metric	Period	Value
Shares Outstanding	Q3 2022 · Jan 31, 2022	14.94M sh
Operating Cash Flow	Q3 2022 · Jan 31, 2022	−$120.52K
Operating Cash Flow	Q3 2022 · Jan 31, 2021	$28.57K
Stockholders Equity	Q3 2022 · Jan 31, 2022	$0
Stockholders Equity	Q3 2022 · Apr 30, 2021	$1.74M
Current Liabilities	Q3 2022 · Jan 31, 2022	$2.99M
Current Liabilities	Q3 2022 · Apr 30, 2021	$127.53K
Current Assets	Q3 2022 · Jan 31, 2022	$2.97M
Current Assets	Q3 2022 · Apr 30, 2021	$1.69M
Total Assets	Q3 2022 · Jan 31, 2022	$2.99M
Total Assets	Q3 2022 · Apr 30, 2021	$1.89M
Sga Expense	Q3 2022 · Jan 31, 2022	$355.4K
Sga Expense	Q3 2022 · Jan 31, 2022	$652.46K
Sga Expense	Q3 2022 · Jan 31, 2021	$91.09K
Sga Expense	Q3 2022 · Jan 31, 2021	$293.58K
Rd Expense	Q3 2022 · Jan 31, 2022	$27.25K
Rd Expense	Q3 2022 · Jan 31, 2022	$86.56K
Rd Expense	Q3 2022 · Jan 31, 2021	$43.08K
Rd Expense	Q3 2022 · Jan 31, 2021	$119.92K
Net Income	Q3 2022 · Jan 31, 2022	$763.13K
Net Income	Q3 2022 · Jan 31, 2022	$697.25K
Net Income	Q3 2022 · Jan 31, 2021	−$235
Net Income	Q3 2022 · Jan 31, 2021	$14.69K
Operating Income	Q3 2022 · Jan 31, 2022	−$206.83K
Operating Income	Q3 2022 · Jan 31, 2022	−$300.13K
Operating Income	Q3 2022 · Jan 31, 2021	−$10.43K
Operating Income	Q3 2022 · Jan 31, 2021	$9.23K
Gross Profit	Q3 2022 · Jan 31, 2022	$197.88K
Gross Profit	Q3 2022 · Jan 31, 2022	$517.72K
Gross Profit	Q3 2022 · Jan 31, 2021	$165.78K
Gross Profit	Q3 2022 · Jan 31, 2021	$548.92K
Cost Of Revenue	Q3 2022 · Jan 31, 2022	$128.16K
Cost Of Revenue	Q3 2022 · Jan 31, 2022	$505.18K
Cost Of Revenue	Q3 2022 · Jan 31, 2021	$99.32K
Cost Of Revenue	Q3 2022 · Jan 31, 2021	$321.14K